Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Tuesday, April 21, 2015

Cantrixil Receives Orphan Drug Designation from FDA

Orphan Drug Designation is an important development for any experimental drug and has been instigated in a number of territories including the U.S, Cantrixil was granted Orphan Drug Designation under the U.S. Orphan drug Act following a review by the FDA of a package of pre-clinical data submitted by the Company.
http://ift.tt/1OEecFn

No comments:

Post a Comment

Popular Stem Cell Roundup Posts